-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on March 1 Recently, the three major Chinese medicinal material markets released a summary of 2020 and an outlook for 2021
.
In general, in 2021, under the support of favorable factors such as continued growth in demand for Chinese medicinal materials, reduced planting expectations, steady economic growth, and continuous rise in food prices, the market prospects are worth looking forward to
.
These traditional Chinese medicines are worth paying attention
to.
According to the January market fluctuation table released by the four major pharmaceutical markets in Bozhou Pharmaceutical Market, it can be seen that in recent days, the price of Wang Buliuhang has risen the most, and the prices of epidemic star Banlangen, Forsythia and Honeysuckle have risen.
The price of star anise, a seasoning drug that has recently attracted much attention, has been relatively stable, but the price of similar drugs, white cardamom, has fluctuated greatly
.
Bozhou market quotation table (picture source: Chinese herbal medicine Tiandi.
com) In fact, Wang Buliu has not seen a significant increase in demand.
This price increase is due to years of low prices, farmers abandoning seeds, and inventory is digested
.
From the perspective of Wang Buliu’s planting and harvesting rules and the impact of grain prices, short-term inventories will not be replenished too much, and the probability of price correction is low.
The market outlook is expected to continue to improve until planting production resumes
.
In addition to being affected by the epidemic, the increase in the price of Forsythia may be due to the addition of volatile oil testing items to the determination of the content of Forsythia in the 2020 Chinese Pharmacopoeia.
The clarity of Forsythia has increased and the cost has risen.
If nothing unexpected happens, the market will continue to rise.
.
In addition, due to the "falling spring cold" in March and April has a greater impact on the price of Forsythia, due to the weather, the market for Forsythia is uncertain.
In addition, Forsythia is very commonly used in various antiviral formulas and is the most sensitive.
Once there is strong demand for the epidemic varieties, it is also possible to jump up
.
The price increase of star anise is mainly due to the successive year-on-year reduction in production and the digestion of stocks.
The price will continue to be high before the new Dahong production in 2021.
However, due to the impact of drought in the production area on growth, the output in 2021 may not be large.
.
The white cardamom fell from 285 yuan to 170 yuan in December, and this period fell from 170 yuan to 80 yuan, a drop of more than 40% for two consecutive periods
.
This is mainly because the previous price fluctuations of white cardamom were mainly affected by the control of the gate.
The price surged far beyond its own value.
As the gate continued to return to normal traffic, the market fell
.
However, it is worth noting that the price increase of white cardamom after the opening of the market has risen significantly to between 120-130 yuan, and the price has been adjusted to between 130-150 yuan again in the past two days.
Such frequent market fluctuations are more unexpected than the merchants
.
In 2021 , these factors affect the market.
In
2020, the sales of Chinese medicinal materials will be concentrated in the second half of the year.
The rise in prices of medicinal materials is mainly due to the epidemic, customs control, weather and rain.
At the same time, some wild animals and plants have also increased significantly
.
The decline in drug prices was mainly due to the overproduction of pharmaceutical farmers
.
In 2021, 2020, most of these factors will affect the market
.
In terms of home-grown medicinal materials, affected by the general economic situation, the prices of some low-priced Chinese medicinal materials that have been reduced in production may increase in price
.
However, medicinal materials with a large growing area will still face the pressure of overproduction in 2021.
Even if the price bottoms out and rebounds, it will not rise too high, and can only hover around the production cost
.
Such medicinal materials include Atractylodes macrocephala, Radix Paeoniae Alba, Angelica sinensis, Codonopsis pilosula and Salvia miltiorrhiza
.
With the decrease of resources, wild medicinal materials will still lead the market in 2021.
Natural disasters such as atractylodes, white fresh bark, Weilingxian, and natural disasters are one of the factors that affect market changes almost every year, and they are vulnerable to low temperature damage, drought, and floods.
The medicinal materials are: wild jujube kernel, cypress kernel, bitter almond, and forsythia
.
In addition, it is worth noting that the 2020 edition of the Pharmacopoeia is fully implemented this year, and the 33 new pesticide residues and heavy metal determinations in the Pharmacopoeia are a major change in the Chinese medicine industry
.
New standards for Chinese medicinal materialsThe new requirements for pesticide residues and heavy metals will cause many medicinal materials to face sales difficulties due to quality problems, but medicinal materials that meet the pharmacopoeial standards of high quality and good price will also be sought after by the market, such as ginseng with low pesticide residues, qualified Peucedanum, and content.
high of new goods berberine, wild Notopterygium, aflatoxin and so does not exceed the Bozi
.
Decoction pieces enterprises will also usher in a new round of reshuffle.
Only large decoction pieces factories can survive if they meet the conditions of national supervision and have the ability to regulate
.
It will be more difficult for relatively small decoction pieces factories .
As the country attaches great importance to the development of the Chinese medicine industry, many Chinese medicine companies have ushered in new development opportunities, but opportunities and challenges coexist.
The new version of the Pharmacopoeia has been fully implemented, and there are stricter requirements on the standards of many varieties, which has improved pharmaceutical companies.
The cost is a challenge for pharmaceutical companies
.
In medicine is essential Chinese medicine, the price trend worth noting
.
.
In general, in 2021, under the support of favorable factors such as continued growth in demand for Chinese medicinal materials, reduced planting expectations, steady economic growth, and continuous rise in food prices, the market prospects are worth looking forward to
.
These traditional Chinese medicines are worth paying attention
to.
According to the January market fluctuation table released by the four major pharmaceutical markets in Bozhou Pharmaceutical Market, it can be seen that in recent days, the price of Wang Buliuhang has risen the most, and the prices of epidemic star Banlangen, Forsythia and Honeysuckle have risen.
The price of star anise, a seasoning drug that has recently attracted much attention, has been relatively stable, but the price of similar drugs, white cardamom, has fluctuated greatly
.
Bozhou market quotation table (picture source: Chinese herbal medicine Tiandi.
com) In fact, Wang Buliu has not seen a significant increase in demand.
This price increase is due to years of low prices, farmers abandoning seeds, and inventory is digested
.
From the perspective of Wang Buliu’s planting and harvesting rules and the impact of grain prices, short-term inventories will not be replenished too much, and the probability of price correction is low.
The market outlook is expected to continue to improve until planting production resumes
.
In addition to being affected by the epidemic, the increase in the price of Forsythia may be due to the addition of volatile oil testing items to the determination of the content of Forsythia in the 2020 Chinese Pharmacopoeia.
The clarity of Forsythia has increased and the cost has risen.
If nothing unexpected happens, the market will continue to rise.
.
In addition, due to the "falling spring cold" in March and April has a greater impact on the price of Forsythia, due to the weather, the market for Forsythia is uncertain.
In addition, Forsythia is very commonly used in various antiviral formulas and is the most sensitive.
Once there is strong demand for the epidemic varieties, it is also possible to jump up
.
The price increase of star anise is mainly due to the successive year-on-year reduction in production and the digestion of stocks.
The price will continue to be high before the new Dahong production in 2021.
However, due to the impact of drought in the production area on growth, the output in 2021 may not be large.
.
The white cardamom fell from 285 yuan to 170 yuan in December, and this period fell from 170 yuan to 80 yuan, a drop of more than 40% for two consecutive periods
.
This is mainly because the previous price fluctuations of white cardamom were mainly affected by the control of the gate.
The price surged far beyond its own value.
As the gate continued to return to normal traffic, the market fell
.
However, it is worth noting that the price increase of white cardamom after the opening of the market has risen significantly to between 120-130 yuan, and the price has been adjusted to between 130-150 yuan again in the past two days.
Such frequent market fluctuations are more unexpected than the merchants
.
In 2021 , these factors affect the market.
In
2020, the sales of Chinese medicinal materials will be concentrated in the second half of the year.
The rise in prices of medicinal materials is mainly due to the epidemic, customs control, weather and rain.
At the same time, some wild animals and plants have also increased significantly
.
The decline in drug prices was mainly due to the overproduction of pharmaceutical farmers
.
In 2021, 2020, most of these factors will affect the market
.
In terms of home-grown medicinal materials, affected by the general economic situation, the prices of some low-priced Chinese medicinal materials that have been reduced in production may increase in price
.
However, medicinal materials with a large growing area will still face the pressure of overproduction in 2021.
Even if the price bottoms out and rebounds, it will not rise too high, and can only hover around the production cost
.
Such medicinal materials include Atractylodes macrocephala, Radix Paeoniae Alba, Angelica sinensis, Codonopsis pilosula and Salvia miltiorrhiza
.
With the decrease of resources, wild medicinal materials will still lead the market in 2021.
Natural disasters such as atractylodes, white fresh bark, Weilingxian, and natural disasters are one of the factors that affect market changes almost every year, and they are vulnerable to low temperature damage, drought, and floods.
The medicinal materials are: wild jujube kernel, cypress kernel, bitter almond, and forsythia
.
In addition, it is worth noting that the 2020 edition of the Pharmacopoeia is fully implemented this year, and the 33 new pesticide residues and heavy metal determinations in the Pharmacopoeia are a major change in the Chinese medicine industry
.
New standards for Chinese medicinal materialsThe new requirements for pesticide residues and heavy metals will cause many medicinal materials to face sales difficulties due to quality problems, but medicinal materials that meet the pharmacopoeial standards of high quality and good price will also be sought after by the market, such as ginseng with low pesticide residues, qualified Peucedanum, and content.
high of new goods berberine, wild Notopterygium, aflatoxin and so does not exceed the Bozi
.
Decoction pieces enterprises will also usher in a new round of reshuffle.
Only large decoction pieces factories can survive if they meet the conditions of national supervision and have the ability to regulate
.
It will be more difficult for relatively small decoction pieces factories .
As the country attaches great importance to the development of the Chinese medicine industry, many Chinese medicine companies have ushered in new development opportunities, but opportunities and challenges coexist.
The new version of the Pharmacopoeia has been fully implemented, and there are stricter requirements on the standards of many varieties, which has improved pharmaceutical companies.
The cost is a challenge for pharmaceutical companies
.
In medicine is essential Chinese medicine, the price trend worth noting
.
